Cochlear implantation surgery
Conditions
Interventions
EC50 group:The initial target controlled infusion concentration of remifentanil is 2.0 ng/mL, and according to the sequential method, it is preset to be adjusted in a gradient of 0.2 ng/mL. Based on t
1: mild cough, only once, no agitation
2: moderate cough,>once, but lastingonce, but lasting<5s, with agitation but not affecting extubation
3: Persistent cough for more than 5 seconds, accompanied by head lifting, breath holding, cyanosis, etc. Once the MAP or HR exceeds 20% of the baseline value and/or moderate to severe coughing occurs,
Sponsors
Shandong Second Provincial General Hospital
Eligibility
Sex/Gender
All
Age
6 Years to 12 Years
Inclusion criteria
Inclusion criteria: (1) Age 6-12 years old; (2) American Society of Anesthesiologists (ASA) grades I-II; (3) Selective cochlear implantation surgery for pedestrians, with a surgery time of 1-2 hours; (4) Plan to undergo general anesthesia; (5) Sign informed consent forms, conduct pain scoring education, and cooperate in data collection.
Exclusion criteria
Exclusion criteria: (1) The surgery time is greater than 2 hours; (2) Preoperative concomitant congenital cardiovascular disease; (3) Difficult airway assessment; (4) Suffering from severe heart disease; (5)BMI >= 30 kg/m^2; (6) History of chronic pain or opioid use; (7) Any other reasons that prevent cooperation with the study, such as congenital mental illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart rate;Mean arterial pressure;Depth of anesthesia; | — |
Countries
China
Contacts
Public ContactJuan Zhao
Shandong Second Provincial General Hospital
Outcome results
None listed